Economic outcomes of colfosceril palmitate rescue therapy in infants weighing 1250g or more with respiratory distress syndrome: results from a randomised trial (Q74824117)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1994

Language	Label	Description	Also known as
English	Economic outcomes of colfosceril palmitate rescue therapy in infants weighing 1250g or more with respiratory distress syndrome: results from a randomised trial	scientific article published on 01 October 1994

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Economic outcomes of colfosceril palmitate rescue therapy in infants weighing 1250g or more with respiratory distress syndrome: results from a randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

colfosceril palmitate

1 reference

based on heuristic

inferred from title

author name string

M E Backhouse

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J A Mauskopf

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

D Jones

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

D E Wold

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

R Schumacher

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

R Cotton

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

W A Long

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 October 1994

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

358-369

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10147473%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surfactant replacement therapy: impact on hospital charges for premature infants with respiratory distress syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased survival rate in very low birth weight infants (1500 grams or less): no association with increased incidence of handicaps

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of neonatal intensive care of very-low-birth-weight infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic consequences of surfactant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost implications of different approaches to the prevention of respiratory distress syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distinction between cost and charges

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of changing clinical practices in the rising costs of hospital care

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effects of surfactant therapy for neonatal respiratory distress syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective pricing system for tertiary neonatal intensive care

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Newborn intensive care and neonatal mortality in low-birth-weight infants: a population study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Newborn risk factors and costs of neonatal intensive care.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of surfactant replacement in preterm babies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10147473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74824117&oldid=2220391002"